Our findings identify PMVECs as previously unrecognized essential mediators of antiviral immunity, as they directly present viral antigens and activate CD8+ T cells, highlighting the EC–T cell axis as a critical modulator of host defense and a potential therapeutic target in severe influenza and other viral pneumonia. Here, CD8A is linked to viral pneumonia.